Page last updated: 2024-08-22

ruthenium and Hypoxia

ruthenium has been researched along with Hypoxia in 15 studies

Research

Studies (15)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (6.67)18.2507
2000's2 (13.33)29.6817
2010's7 (46.67)24.3611
2020's5 (33.33)2.80

Authors

AuthorsStudies
Barrett, PC; Cameron, CG; Cole, HD; Hodges, RO; Lifshits, LM; McFarland, SA; Ramasamy, E; Roque, JA; Shi, G1
Cheng, B; Hong, XJ; Li, WG; Ling, YY; Mao, ZW; Su, Q; Tan, CP; Wang, WJ; Wu, T; Zhang, CY; Zhou, JY1
Dao, A; Huang, H; Wei, S; Wu, H1
Wilson, JJ; Woods, JJ1
Chao, H; Ji, L; Kuang, S; Liao, X; Liu, J; Luo, D; Rees, TW; Wang, J; Wei, F; Zhang, X1
Askes, SHC; Bonnet, S; Ernst, D; Hopkins, SL; Lameijer, LN; Le Dévédec, SE; Meijer, MS1
Achilefu, S; Black, KCL; Gilson, RC; Lane, DD1
Bu, J; Bu, W; Du, J; Liu, J; Liu, Y; Shi, J; Sun, Y1
Allison, SJ; Hebden, AJ; Henderson, IR; Lord, RM; McGowan, PC; Pask, CM; Phillips, RM; Shepherd, SL1
Chao, H; Chen, Y; Huang, H; Ji, L; Wang, J; Zeng, L; Zhao, D1
Glover, CJ; Gransbury, GK; Harris, HH; Hughes, JN; Kappen, P; Lay, PA; Levina, A; Musgrave, IF1
Kimura, Y; Komatsu, H; Nishimoto, S; Son, A; Tanabe, K; Yamada, H; Yoshihara, K1
Aldinucci, C; Benocci, A; Frosini, M; Garcia, JB; Meini, A; Palmi, M; Pessina, GP; Sgaragli, GP1
Chaplin, DJ; Collingridge, DR; Hill, SA; Lynch, EM; Vojnovic, B; Wardman, P; Young, WK1
Blower, PJ; Dilworth, JR; Maurer, RI; Mullen, GD; Reynolds, CA; Zheng, Y1

Reviews

1 review(s) available for ruthenium and Hypoxia

ArticleYear
Towards new transition metal-based hypoxic selective agents for therapy and imaging.
    Journal of inorganic biochemistry, 2001, Volume: 85, Issue:1

    Topics: Antineoplastic Agents, Alkylating; Copper; Drug Carriers; Humans; Hypoxia; Metals; Nitrogen Mustard Compounds; Radioisotopes; Radionuclide Imaging; Rhenium; Ruthenium

2001

Other Studies

14 other study(ies) available for ruthenium and Hypoxia

ArticleYear
Anticancer Agent with Inexplicable Potency in Extreme Hypoxia: Characterizing a Light-Triggered Ruthenium Ubertoxin.
    Journal of the American Chemical Society, 2022, 06-08, Volume: 144, Issue:22

    Topics: Antineoplastic Agents; Cell Line, Tumor; Humans; Hypoxia; Photochemotherapy; Photosensitizing Agents; Reproducibility of Results; Ruthenium

2022
Ru(II)-modified TiO
    Biomaterials, 2022, Volume: 289

    Topics: Animals; Carcinoma, Squamous Cell; Cell Line, Tumor; Cytokines; Head and Neck Neoplasms; Humans; Hypoxia; Hypoxia-Inducible Factor 1, alpha Subunit; Immunotherapy; Metal Nanoparticles; Mouth Neoplasms; Nanoparticles; Photosensitizing Agents; Rats; RNA, Small Interfering; Ruthenium; Squamous Cell Carcinoma of Head and Neck; Titanium; Tumor Microenvironment

2022
Novel Ru(II) complexes with multiple anticancer photoreactivity: ligand exchange, photoredox catalysis, reactive oxygen generation and endoperoxide formation.
    Physical chemistry chemical physics : PCCP, 2023, Jul-26, Volume: 25, Issue:29

    Topics: Antineoplastic Agents; Cell Line, Tumor; Coordination Complexes; Humans; Hypoxia; Ligands; Oxygen; Photochemotherapy; Photosensitizing Agents; Reactive Oxygen Species; Ruthenium

2023
A Dinuclear Persulfide-Bridged Ruthenium Compound is a Hypoxia-Selective Hydrogen Sulfide (H
    Angewandte Chemie (International ed. in English), 2021, 01-18, Volume: 60, Issue:3

    Topics: Animals; Coordination Complexes; Hydrogen Sulfide; Hypoxia; Oxidation-Reduction; Rats; Ruthenium; Sulfides

2021
Ruthenium(II) complexes coordinated to graphitic carbon nitride: Oxygen self-sufficient photosensitizers which produce multiple ROS for photodynamic therapy in hypoxia.
    Biomaterials, 2021, Volume: 276

    Topics: Graphite; Humans; Hydrogen Peroxide; Hypoxia; Nitrogen Compounds; Oxygen; Photochemotherapy; Photosensitizing Agents; Reactive Oxygen Species; Ruthenium

2021
A Red-Light-Activated Ruthenium-Caged NAMPT Inhibitor Remains Phototoxic in Hypoxic Cancer Cells.
    Angewandte Chemie (International ed. in English), 2017, 09-11, Volume: 56, Issue:38

    Topics: Antineoplastic Agents; Cell Line; Cell Proliferation; Cell Survival; Cytokines; Dose-Response Relationship, Drug; Drug Screening Assays, Antitumor; Enzyme Inhibitors; Humans; Hypoxia; Light; Nicotinamide Phosphoribosyltransferase; Organometallic Compounds; Photochemical Processes; Photochemotherapy; Ruthenium; Structure-Activity Relationship

2017
Hybrid TiO
    Angewandte Chemie (International ed. in English), 2017, 08-28, Volume: 56, Issue:36

    Topics: Hypoxia; Nanoparticles; Photochemotherapy; Photosensitizing Agents; Reactive Oxygen Species; Ruthenium; Titanium

2017
Ultrasensitive nanosensors based on upconversion nanoparticles for selective hypoxia imaging in vivo upon near-infrared excitation.
    Journal of the American Chemical Society, 2014, Jul-09, Volume: 136, Issue:27

    Topics: Adsorption; Animals; Cell Line, Tumor; Humans; Hypoxia; Microscopy, Confocal; Molecular Structure; Nanoparticles; Nanotechnology; Organometallic Compounds; Oxygen; Particle Size; Ruthenium; Surface Properties; Zebrafish

2014
Hypoxia-Sensitive Metal β-Ketoiminato Complexes Showing Induced Single-Strand DNA Breaks and Cancer Cell Death by Apoptosis.
    Journal of medicinal chemistry, 2015, Jun-25, Volume: 58, Issue:12

    Topics: Antineoplastic Agents; Apoptosis; Cell Line; Cell Line, Tumor; Coordination Complexes; Crystallography, X-Ray; DNA Breaks, Single-Stranded; Humans; Hypoxia; Iridium; Models, Molecular; Neoplasms; Ruthenium

2015
Cyclometalated Ruthenium(II) Anthraquinone Complexes Exhibit Strong Anticancer Activity in Hypoxic Tumor Cells.
    Chemistry (Weinheim an der Bergstrasse, Germany), 2015, Oct-19, Volume: 21, Issue:43

    Topics: Anthraquinones; Antineoplastic Agents; Apoptosis; Cell Line, Tumor; Coordination Complexes; HeLa Cells; Hep G2 Cells; Humans; Hypoxia; Ligands; Lung Neoplasms; Ruthenium

2015
Comparison of KP1019 and NAMI-A in tumour-mimetic environments.
    Metallomics : integrated biometal science, 2016, 08-01, Volume: 8, Issue:8

    Topics: Antineoplastic Agents; Dimethyl Sulfoxide; Humans; Hypoxia; Indazoles; Neuroblastoma; Organometallic Compounds; Ruthenium; Ruthenium Compounds; Spheroids, Cellular; Tumor Cells, Cultured; Tumor Microenvironment; X-Ray Absorption Spectroscopy

2016
Ruthenium complexes with hydrophobic ligands that are key factors for the optical imaging of physiological hypoxia.
    Chemistry (Weinheim an der Bergstrasse, Germany), 2013, Feb-04, Volume: 19, Issue:6

    Topics: Animals; Coordination Complexes; Hydrophobic and Hydrophilic Interactions; Hypoxia; Ligands; Luminescent Measurements; Mice; Molecular Structure; Optical Imaging; Phenanthrolines; Photochemistry; Pyrenes; Pyridines; Ruthenium

2013
Potentiation of intracellular Ca2+ mobilization by hypoxia-induced NO generation in rat brain striatal slices and human astrocytoma U-373 MG cells and its involvement in tissue damage.
    The European journal of neuroscience, 2003, Volume: 17, Issue:4

    Topics: Animals; Anticoagulants; Astrocytoma; Calcium; Cell Line, Tumor; Corpus Striatum; Cyclic N-Oxides; Dose-Response Relationship, Drug; Drug Combinations; Drug Interactions; Enzyme Inhibitors; Free Radical Scavengers; Fura-2; Heparin; Humans; Hydro-Lyases; Hypoxia; Imidazoles; In Vitro Techniques; Intracellular Space; Male; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitric Oxide Donors; Nitroprusside; Perfusion; Rats; Rats, Sprague-Dawley; Ruthenium; Ryanodine

2003
Measurement of tumor oxygenation: a comparison between polarographic needle electrodes and a time-resolved luminescence-based optical sensor.
    Radiation research, 1997, Volume: 147, Issue:3

    Topics: Animals; Female; Fluorescent Dyes; Hypoxia; Luminescent Measurements; Mice; Mice, Inbred CBA; Organometallic Compounds; Oxygen; Phenanthrolines; Polarography; Ruthenium; Sarcoma, Experimental

1997